Cargando…

Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma

BACKGROUND: The peritumoral stroma is a hallmark of pancreatic ductal adenocarcinoma (PDA) with implications for disease development, progression and therapy resistance. We systematically investigated immune features of the stroma in PDA patients to identify markers of clinical importance and potent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Azaz, Klotz, Rosa, Köhler, Sophia, Giese, Nathalia, Hackert, Thilo, Springfeld, Christoph, Jäger, Dirk, Halama, Niels
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483939/ https://www.ncbi.nlm.nih.gov/pubmed/36131941 http://dx.doi.org/10.3389/fimmu.2022.947407

Ejemplares similares

Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2022)

Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of IL2 and MIF with prognostic significance in resectable pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2021)

Sex Differences in the Systemic and Local Immune Response of Pancreatic Cancer Patients
por: Ahmed, Azaz, et al.
Publicado: (2023)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
por: Wei, Kongyuan, et al.
Publicado: (2021)

Diffusion Kurtosis Imaging—A Superior Approach to Assess Tumor–Stroma Ratio in Pancreatic Ductal Adenocarcinoma
por: Mayer, Philipp, et al.
Publicado: (2020)

Comparative Characterization of Stroma Cells and Ductal Epithelium in Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma
por: Helm, Ole, et al.
Publicado: (2014)

Prognostic Implications of Intratumoral and Peritumoral Infiltrating Lymphocytes in Pancreatic Ductal Adenocarcinoma
por: Pyo, Jung-Soo, et al.
Publicado: (2021)

Myofibroblastic CAF Density, Not Activated Stroma Index, Indicates Prognosis after Neoadjuvant Therapy of Pancreatic Carcinoma
por: Heger, Ulrike, et al.
Publicado: (2022)

The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
por: Wang, Lai Mun, et al.
Publicado: (2015)

Transcriptional variations in the wider peritumoral tissue environment of pancreatic cancer
por: Bauer, Andrea S., et al.
Publicado: (2017)

Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
por: Gebauer, Florian, et al.
Publicado: (2017)

Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2019)

Pancreatic stellate cells regulate blood vessel density in the stroma of pancreatic ductal adenocarcinoma
por: Di Maggio, Francesco, et al.
Publicado: (2016)

SST gene hypermethylation acts as a pan‐cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood‐based diagnosis
por: Manoochehri, Mehdi, et al.
Publicado: (2020)

Comparison of the tumor cell secretome and patient sera for an accurate serum-based diagnosis of pancreatic ductal adenocarcinoma
por: Mustafa, Shakhawan, et al.
Publicado: (2017)

Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
por: Liot, Sophie, et al.
Publicado: (2021)

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
por: Moffitt, Richard A., et al.
Publicado: (2015)

Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma
por: Liu, Dajia, et al.
Publicado: (2020)

The tumor–stroma ratio and the immune microenvironment improve the prognostic prediction of pancreatic ductal adenocarcinoma
por: Lu, Mei, et al.
Publicado: (2023)

Epithelial-to-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma and Pancreatic Tumor Cell Lines: The Role of Neutrophils and Neutrophil-Derived Elastase
por: Große-Steffen, Thomas, et al.
Publicado: (2012)

Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma
por: Ghassem-Zadeh, Sahar, et al.
Publicado: (2017)

Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma
por: Jiang, Jiahong, et al.
Publicado: (2021)

Tumor Stroma Area and Other Prognostic Factors in Pancreatic Ductal Adenocarcinoma Patients Submitted to Surgery
por: Amaral, Maria João, et al.
Publicado: (2023)

Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma
por: Askan, Gokce, et al.
Publicado: (2021)

3D heterospecies spheroids of pancreatic stroma and cancer cells demonstrate key phenotypes of pancreatic ductal adenocarcinoma
por: Liu, Xinyuan, et al.
Publicado: (2021)

Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma
por: Daunke, Tina, et al.
Publicado: (2023)

Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis by Measurement of microRNA Abundance in Blood and Tissue
por: Bauer, Andrea S., et al.
Publicado: (2012)

High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma
por: Huang, Jianfei, et al.
Publicado: (2015)

Molecular profiling of stroma highlights stratifin as a novel biomarker of poor prognosis in pancreatic ductal adenocarcinoma
por: Robin, Fabien, et al.
Publicado: (2020)

CT Radiomics and Machine-Learning Models for Predicting Tumor-Stroma Ratio in Patients With Pancreatic Ductal Adenocarcinoma
por: Meng, Yinghao, et al.
Publicado: (2021)

Imaging features of intraductal tubulopapillary neoplasm of the pancreas and its differentiation from conventional pancreatic ductal adenocarcinoma
por: Khristenko, Ekaterina, et al.
Publicado: (2022)

CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
por: Noll, Elisa M., et al.
Publicado: (2016)

Palliative chemotherapy for pancreatic adenocarcinoma: a retrospective cohort analysis of efficacy and toxicity of the FOLFIRINOX regimen focusing on the older patient
por: Berger, Anne Katrin, et al.
Publicado: (2017)

In Silico analyses of host immunity and stroma provide prognostic factors in early stage pancreatic ductal adenocarcinoma (PDAC)
por: Williams, Madison H., et al.
Publicado: (2020)

Collagen Organization Does Not Influence T-Cell Distribution in Stroma of Human Pancreatic Cancer
por: Kamionka, Eva-Maria, et al.
Publicado: (2021)

Protocol of a prospective, monocentric phase I/II feasibility study investigating the safety of multimodality treatment with a combination of intraoperative chemotherapy and surgical resection in locally confined or borderline resectable pancreatic cancer: the combiCaRe study
por: Roth, Susanne, et al.
Publicado: (2019)

High expression of both desmoplastic stroma and epithelial to mesenchymal transition markers associate with shorter survival in pancreatic ductal adenocarcinoma
por: Sánchez-Ramírez, Damián, et al.
Publicado: (2022)

Prognostic Significance of Erythropoietin in Pancreatic Adenocarcinoma
por: Welsch, Thilo, et al.
Publicado: (2011)

Overcoming chemoresistance in pancreatic cancer cells: role of the bitter taste receptor T2R10
por: Stern, Louisa, et al.
Publicado: (2018)

Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels
por: Seifert, Adrian M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jk2s87ehfmtgpe1ol9gh3aacka